secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2024-11-19T23:59:59+00:00
Accession:  0001493152-24-046849
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharma appoints director Fry (420K options); amends CFO pay (£400K, 40% bonus) and quorum rule
--------------------------------------------------------------------------------

- Simon Fry appointed as director effective Dec 18, 2024; receives initial option for 420,000 common shares.
- CFO James Bligh's employment amendment: £400K base salary, discretionary bonus up to 40%, 6-month notice.
- Bylaws amended: quorum reduced from majority to one-third voting power, effective after 2024 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000149315224046849/0001493152-24-046849-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000149315224046849/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-046849

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer